Data review from the Phase III Discover-2 Trials

Join Jessica Farrell, a clinical pharmacist at Albany Medical Center's Division of Rheumatology and faculty member at Albany College of Pharmacy and Health Sciences, as she reviews data from the Phase III DISCOVER-2 trials. These trials evaluate the long-term efficacy and safety of guselkumab in biologic-naive patients with active psoriatic arthritis.